JP2019073561A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019073561A5 JP2019073561A5 JP2019030302A JP2019030302A JP2019073561A5 JP 2019073561 A5 JP2019073561 A5 JP 2019073561A5 JP 2019030302 A JP2019030302 A JP 2019030302A JP 2019030302 A JP2019030302 A JP 2019030302A JP 2019073561 A5 JP2019073561 A5 JP 2019073561A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- component
- skin
- ionic liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 27
- 239000002608 ionic liquid Substances 0.000 claims 8
- 150000001768 cations Chemical class 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- 208000017520 skin disease Diseases 0.000 claims 4
- 125000000129 anionic group Chemical group 0.000 claims 3
- 150000001450 anions Chemical class 0.000 claims 3
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000000813 microbial effect Effects 0.000 claims 3
- 125000002091 cationic group Chemical group 0.000 claims 2
- 229960001231 choline Drugs 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 208000010201 Exanthema Diseases 0.000 claims 1
- 206010016936 Folliculitis Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 229960005475 antiinfective agent Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 239000007844 bleaching agent Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 201000005884 exanthem Diseases 0.000 claims 1
- ZHYZQXUYZJNEHD-VQHVLOKHSA-M geranate Chemical compound CC(C)=CCC\C(C)=C\C([O-])=O ZHYZQXUYZJNEHD-VQHVLOKHSA-M 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000004530 micro-emulsion Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 206010037844 rash Diseases 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899294P | 2013-11-03 | 2013-11-03 | |
| US61/899,294 | 2013-11-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552446A Division JP2016535781A (ja) | 2013-11-03 | 2014-11-03 | 経皮薬物送達のためのイオン性液体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020037741A Division JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019073561A JP2019073561A (ja) | 2019-05-16 |
| JP2019073561A5 true JP2019073561A5 (enExample) | 2019-08-29 |
| JP6674058B2 JP6674058B2 (ja) | 2020-04-01 |
Family
ID=53005413
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552446A Withdrawn JP2016535781A (ja) | 2013-11-03 | 2014-11-03 | 経皮薬物送達のためのイオン性液体 |
| JP2019030302A Active JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
| JP2020037741A Withdrawn JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552446A Withdrawn JP2016535781A (ja) | 2013-11-03 | 2014-11-03 | 経皮薬物送達のためのイオン性液体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020037741A Withdrawn JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10449254B2 (enExample) |
| EP (1) | EP3062819B1 (enExample) |
| JP (3) | JP2016535781A (enExample) |
| KR (1) | KR102286115B1 (enExample) |
| CA (2) | CA3100536A1 (enExample) |
| ES (1) | ES2908345T3 (enExample) |
| WO (1) | WO2015066647A2 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2463181B (en) | 2007-05-14 | 2013-03-27 | Univ New York State Res Found | Induction of a physiological dispersion response in bacterial cells in a biofilm |
| EP3395368A1 (en) * | 2014-10-30 | 2018-10-31 | Asahi Kasei Kabushiki Kaisha | Transdermal absorption enhancer and transdermal absorption enhancement aid |
| CA2931913C (en) | 2015-06-12 | 2024-03-19 | Kemira Oyj | Bitumen separation using ionic liquids comprising unsubstituted or substituted primary, secondary or tertiary amines, pyridines, amidines, guanidines and fatty acids and/or resin acids |
| WO2018044920A1 (en) | 2016-08-29 | 2018-03-08 | The Regents Of The University Of California | Topical formulations based on ionic species for skin treatment |
| US11274137B1 (en) * | 2016-10-04 | 2022-03-15 | United States Of America As Represented By The Secretary Of The Air Force | Ultra-stable protein ionic liquids |
| US10828265B2 (en) | 2016-12-09 | 2020-11-10 | The Regents Of The University Of California | Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery |
| WO2018222924A1 (en) | 2017-06-01 | 2018-12-06 | Arizona Board Of Regents On Behalf Of Northern Arizona University | Antibiofilm formulations |
| CN111918644A (zh) * | 2017-11-17 | 2020-11-10 | 哈佛大学校长及研究员协会 | 用于内部递送的离子液体 |
| JP2019131480A (ja) * | 2018-01-29 | 2019-08-08 | 旭化成株式会社 | 経皮吸収促進剤及び経皮製剤 |
| AU2019239949B2 (en) * | 2018-03-19 | 2025-06-12 | Cage Bio Inc. | Ionic liquid compositions for treatment of rosacea |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| KR101959524B1 (ko) * | 2018-09-19 | 2019-03-18 | 주식회사 우신라보타치 | 리도카인을 포함한 이온토포레시스용 점착성 카타플라스마 시스템 |
| EP3930757A1 (en) | 2019-03-01 | 2022-01-05 | President And Fellows Of Harvard College | Methods and compositions for protein delivery |
| WO2020205409A1 (en) | 2019-04-03 | 2020-10-08 | President And Fellows Of Harvard College | Ionic liquids for drug delivery |
| EP3744312B1 (en) * | 2019-05-29 | 2022-03-23 | Assistance Publique, Hopitaux De Paris | Green tea catechins eutectic system |
| EP4054527A4 (en) * | 2019-11-08 | 2023-12-06 | Cage Bio Inc. | TOPICAL ADMINISTRATION OF TOFACITINIB USING AN IONIC LIQUID |
| JP2023503899A (ja) * | 2019-11-22 | 2023-02-01 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 薬物送達のためのイオン液体 |
| US20230087487A1 (en) * | 2019-12-09 | 2023-03-23 | Cage Bio, Inc. | Topical delivery of rna interference agents using ionic liquid |
| US11684594B2 (en) | 2020-05-12 | 2023-06-27 | President And Fellows Of Harvard College | Antifungal prophylaxis for cornea |
| US20230329988A1 (en) * | 2020-06-26 | 2023-10-19 | Cage Bio Inc. | Sanitizing compositions containing ionic liquid |
| EP4225324A4 (en) * | 2020-10-05 | 2024-11-13 | Cage Bio Inc. | IONIC LIQUID COMPOSITIONS FOR SKIN DISEASES AND CONDITIONS |
| CN116322658B (zh) | 2020-10-29 | 2025-09-26 | 久光制药株式会社 | 含罗匹尼罗的贴附剂及罗匹尼罗的皮肤透过性的提升方法 |
| KR20230105332A (ko) * | 2020-11-13 | 2023-07-11 | 유니베르시다데 도 미노 | 공융 조성물, 방법 및 이의 용도 |
| WO2022256291A1 (en) | 2021-06-01 | 2022-12-08 | President And Fellows Of Harvard College | Hydrogel devices for drug delivery to the ear |
| WO2022271537A1 (en) | 2021-06-25 | 2022-12-29 | President And Fellows Of Harvard College | Compositions and methods relating to injectable microemulsions |
| US12005134B2 (en) | 2021-06-30 | 2024-06-11 | Abe Pharmaceutical | Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth |
| CA3233824A1 (en) | 2021-10-08 | 2023-04-13 | Samir Mitragotri | Ionic liquids for drug delivery |
| WO2023086499A1 (en) | 2021-11-10 | 2023-05-19 | I2O Therapeutics, Inc. | Ionic liquid compositions |
| CN116474153B (zh) * | 2022-01-17 | 2024-09-27 | 四川大学 | 一种基于竹纤维-低共熔溶剂-明胶的皮肤溃疡护理贴膜 |
| US12109303B2 (en) | 2022-04-18 | 2024-10-08 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions and methods of their use |
| CN115671285B (zh) * | 2022-08-24 | 2024-01-05 | 上海市皮肤病医院 | 一种抗真菌溶液及其制备方法和应用 |
| WO2025147130A1 (ko) * | 2024-01-03 | 2025-07-10 | 주식회사 바이온리퀴드 | 이온성 액체 또는 공융 용매를 이용한 신규 약물제형 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3342840A (en) * | 1964-03-23 | 1967-09-19 | Shell Oil Co | Cationic ester production |
| US4042327A (en) | 1976-01-15 | 1977-08-16 | Waters Associates, Inc. | Ion-pairing chromatography |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JPS62209523A (ja) | 1986-03-11 | 1987-09-14 | Fuji Photo Film Co Ltd | 感光材料 |
| US4892737A (en) * | 1988-09-22 | 1990-01-09 | University Of Florida | Composition and method for enhancing permeability of topical drugs |
| HU203372B (en) | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5356802A (en) | 1992-04-03 | 1994-10-18 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease |
| US5487994A (en) | 1992-04-03 | 1996-01-30 | The Johns Hopkins University | Insertion and deletion mutants of FokI restriction endonuclease |
| US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
| US5674908A (en) | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| AU703926B2 (en) * | 1994-03-28 | 1999-04-01 | Trustees Of Columbia University In The City Of New York, The | Composition for inactivating irritants in fluids |
| KR19990022598A (ko) | 1995-06-07 | 1999-03-25 | 다니엘 엘. 캐시앙, 헨리 엘. 노르호프 | 미셀 보호 분석법 |
| US5786571A (en) | 1997-05-09 | 1998-07-28 | Lexmark International, Inc. | Wrapped temperature sensing assembly |
| ES2298438T3 (es) * | 2001-12-21 | 2008-05-16 | Rhodia Inc. | Composiciones estables combinadas de tensioactivos cationicos y anionicos. |
| US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| US6858217B2 (en) * | 2002-03-22 | 2005-02-22 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stabilization of terpenoids in cosmetic compositions |
| EP1661560B1 (en) | 2004-11-22 | 2008-11-05 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal patch comprising a melting point lowering agent |
| US9139850B2 (en) | 2005-05-19 | 2015-09-22 | L'oreal | Vectorization of dsRNA by cationic particles and topical use |
| US8367845B2 (en) | 2006-04-21 | 2013-02-05 | The Trustees Of Boston University | Ionic viscoelastics and viscoelastic salts |
| WO2008031105A1 (en) | 2006-09-08 | 2008-03-13 | Delaval Holdings Ab | Polymeric guanidine salt-based germicides |
| JP4952272B2 (ja) | 2007-01-29 | 2012-06-13 | 株式会社ツムラ | （ｚ）−リグスチリドの製造方法 |
| JP5117732B2 (ja) * | 2007-01-29 | 2013-01-16 | 株式会社 メドレックス | 外用剤用の低刺激性溶解助剤 |
| US8247198B2 (en) | 2007-09-21 | 2012-08-21 | Friedrich Srienc | Enzymatic processing in deep eutectic solvents |
| CN103239721B (zh) | 2007-11-22 | 2016-03-16 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
| US8022014B2 (en) | 2008-03-26 | 2011-09-20 | Shrieve Chemical Products, Inc. | Deep eutectic solvents and applications |
| JP5681883B2 (ja) | 2009-03-27 | 2015-03-11 | 株式会社 メドレックス | 核酸を有効成分とする外用剤組成物 |
| WO2011056545A2 (en) * | 2009-10-26 | 2011-05-12 | Trustees Of Boston University | Antimicrobial ionic liquids |
| WO2011057209A1 (en) | 2009-11-06 | 2011-05-12 | Qlt, Inc. | Acidic ophthalmic formulations |
| CA2783351C (en) | 2009-12-10 | 2021-09-07 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| ES2625847T3 (es) | 2011-11-04 | 2017-07-20 | Lipotec, S.A. | Péptidos que inhiben la actividad de receptores activados y su uso en composiciones cosméticas o farmacéuticas |
| EP2597099B1 (en) | 2011-11-23 | 2018-08-15 | King Saud University | Deep eutectic solvent and method for its preparation |
| EP2740484A1 (en) | 2012-12-05 | 2014-06-11 | Lipotec, S.A. | Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions |
| FR3002452B1 (fr) | 2013-02-28 | 2016-02-12 | Dermaconcept Jmc | Composition dermatologique antimicrobienne topique |
| CN105434337B (zh) | 2015-04-03 | 2019-08-16 | 武汉科福新药有限责任公司 | 盐酸普萘洛尔亚微乳凝胶及其制备方法和用途 |
-
2014
- 2014-11-03 WO PCT/US2014/063745 patent/WO2015066647A2/en not_active Ceased
- 2014-11-03 CA CA3100536A patent/CA3100536A1/en not_active Abandoned
- 2014-11-03 KR KR1020167014980A patent/KR102286115B1/ko active Active
- 2014-11-03 ES ES14859243T patent/ES2908345T3/es active Active
- 2014-11-03 US US15/034,138 patent/US10449254B2/en active Active
- 2014-11-03 JP JP2016552446A patent/JP2016535781A/ja not_active Withdrawn
- 2014-11-03 CA CA2929630A patent/CA2929630C/en active Active
- 2014-11-03 EP EP14859243.9A patent/EP3062819B1/en active Active
-
2019
- 2019-02-22 JP JP2019030302A patent/JP6674058B2/ja active Active
- 2019-06-21 US US16/448,335 patent/US11786597B2/en active Active
-
2020
- 2020-03-05 JP JP2020037741A patent/JP2020097633A/ja not_active Withdrawn
-
2023
- 2023-09-22 US US18/472,966 patent/US20240156964A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019073561A5 (enExample) | ||
| JP2016535781A5 (enExample) | ||
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| ES2720271T3 (es) | Composiciones de gel tópico que contienen un polímero de policaprolactona y métodos para mejorar la aplicación tópica de un agente beneficioso | |
| CN103153290B (zh) | 有助于伤口愈合的抗微生物制剂 | |
| JP2015500794A5 (enExample) | ||
| WO2019193333A1 (en) | Composition for treatment of chronic wounds | |
| JP2015535281A (ja) | 揮発性、疎水性溶媒を用いた生物学的に活性な薬剤の送達 | |
| JP2016540785A5 (enExample) | ||
| KR20120022930A (ko) | 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법 | |
| JP2013519653A (ja) | サキシトキシン誘導体での触覚の喪失の処置 | |
| EP3634342A1 (de) | Silikonpad mit wirkstoffen zur hautpflege und gegen hautalterung | |
| BR112021025701A2 (pt) | Formulações e métodos de parasiticida de isoxazolina para tratar blefarite | |
| CA3092939C (en) | USE OF THE COMBINATION OF KX01 AND VITAMIN D TO TREAT HYPERPROLIFERATIVE SKIN DISORDERS | |
| JP2020519656A5 (enExample) | ||
| WO2007132273A3 (en) | Rinse-off therapeutic agents for treating skin | |
| JP2018525318A (ja) | 爪甲真菌症の予防用または治療用の医薬組成物およびその製造方法 | |
| CN104027341A (zh) | 一种皮肤护理组合物及其制剂 | |
| RU2394557C1 (ru) | Набор средств для лечения угревой болезни | |
| KR101591470B1 (ko) | 키토산 수용액 조성물 | |
| MX2022015792A (es) | Composiciones farmaceuticas topicas. | |
| JP2021165284A5 (enExample) | ||
| AU2021104650A4 (en) | Compositions and methods of use thereof | |
| EP4364812A3 (en) | Intranasal administration of ketamine to cluster headache patients | |
| JPWO2020174443A5 (enExample) |